Login / Signup
Estimating the survival rate in glioblastoma multiforme patients who received a peptide vaccine: a systematic review and meta-analysis.
Masoumeh Eliyasi Dashtaki
Zahra Moradi
Yousef Moradi
Elham Asadi
Sorayya Ghasemi
Published in:
Current drug targets (2023)
Our study found that while peptide vaccination treatment did not increase second-year survival, it improved first-year survival. More research needs to be done to find effective vaccine-based treatments for GBM that can help patients survive longer.
Keyphrases
</>
end stage renal disease
free survival
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
patient reported outcomes
patient reported